The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Mechanisms of TGFβ-Induced Epithelial–Mesenchymal Transition
Open accessAbstract
Transitory phenotypic changes such as the epithelial–mesenchymal transition (EMT) help embryonic cells to generate migratory descendants that populate new sites and establish the distinct tissues in the developing embryo. The mesenchymal descendants of diverse epithelia also participate in the wound healing response of adult tissues, and facilitate the progression of cancer. EMT can be induced by several extracellular cues in the microenvironment of a given epithelial tissue. One such cue, transforming growth factor β (TGFβ), prominently induces EMT via a group of specific transcription factors. The potency of TGFβ is partly based on its ability to perform two parallel molecular functions, i.e. to induce the expression of growth factors, cytokines and chemokines, which sequentially and in a complementary manner help to establish and maintain the EMT, and to mediate signaling crosstalk with other developmental signaling pathways, thus promoting changes in cell differentiation. The molecules that are activated by TGFβ signaling or act as cooperating partners of this pathway are impossible to exhaust within a single coherent and contemporary report. Here, we present selected examples to illustrate the key principles of the circuits that control EMT under the influence of TGFβ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–216 of 216
The TGFβ-Par6 polarity pathway: Linking the Par complex to EMT and breast cancer progression
Viloria‐Petit, A., & Wrana, J. L. (2010) · Cell Cycle · doi:10.4161/cc.9.4.10779 · Cited by 39
Wu, J., Han, J.-L., Hou, B., Deng, C., Wu, H., & Shen, L. (2016) · Oncology Reports · doi:10.3892/or.2016.4638 · Cited by 38
Xia, Y., Yin, L., Jiang, N., Guo, W., Tian, H., Jiang, X.-S., Wu, J., Chen, M., Wu, J.-Z., & He, X. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.068 · Cited by 37
Howley, B. V., Hussey, G. S., Link, L. A., & Howe, P. H. (2015) · Oncogene · doi:10.1038/onc.2015.238 · Cited by 35
Wittmann, P., Grubinger, M., Gröger, C., Huber, H., Sieghart, W., Peck‐Radosavljevic, M., & Mikulits, W. (2015) · BMC Cancer · doi:10.1186/s12885-015-1919-0 · Cited by 34
Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition
Banno, A., Garcia, D. A., Baarsel, E. D. V., Metz, P. J., Fisch, K. M., Widjaja, C. E., Kim, S. H., Lopez, J. M., Chang, A. N., Geurink, P. P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7596 · Cited by 34
Zhou, B., Buckley, S. T., Patel, V., Liu, Y., Luo, J., Krishnaveni, M. S., Ivan, M., DeMaio, L., Kim, K., Ehrhardt, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038827 · Cited by 33
Nguyen, H.-L., Kadam, P., Helkin, A. W., Cao, K., Wu, S., Samara, G. J., Zhang, Q., Zucker, S., & Cao, J. P. (2016) · Current Cancer Drug Targets · doi:10.2174/1568009616666160216125634 · Cited by 32
Järvinen, P. M., & Laiho, M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.004 · Cited by 31
Haraguchi, M., Sato, M., & Ozawa, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132260 · Cited by 30
Bae, E., Kim, S., Hong, S., Liu, F., & Ooshima, A. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.103 · Cited by 29
Jiang, Y. Z., Feng, X., Zheng, L., Li, S., Ge, X., & Zhang, J. (2015) · Oncotarget · doi:10.18632/oncotarget.4635 · Cited by 26
Okayama, A., Miyagi, Y., Oshita, F., Ito, H., Nakayama, H., Nishi, M., Kurata, Y., Kimura, Y., Ryo, A., & Hirano, H. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00082 · Cited by 23
Wu, Y., Fu, Y., Zheng, L., Lin, G., Ma, J., Lou, J.-S., Zhu, H., He, Q., & Yang, B. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.039 · Cited by 20
Role of TGF-β receptor III localization in polarity and breast cancer progression
Meyer, A. E., Gatza, C. E., How, T., Starr, M. D., Nixon, A., & Blobe, G. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-03-0825 · Cited by 19
Regulated Intramembrane Proteolysis of the TGFβ Type I Receptor Conveys Oncogenic Signals
Gudey, S. K., Wallenius, A., & Landström, M. (2014) · Future Oncology · doi:10.2217/fon.14.45 · Cited by 14
Cited by
Puram, S. V., Tirosh, I., Parikh, A. S., Patel, A. P., Yizhak, K., Gillespie, S., Rodman, C., Luo, C. L., Mroz, E. A., Emerick, K. S., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.044 · Cited by 2,557
Targeting TGF-β Signaling in Cancer
Colak, S., & ten Dijke, P. (2017) · Trends in cancer · doi:10.1016/j.trecan.2016.11.008 · Cited by 1,003
Contextual determinants of TGFβ action in development, immunity and cancer
David, C. J., & Massagué, J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0007-0 · Cited by 851
EMT and inflammation: inseparable actors of cancer progression
Suarez‐Carmona, M., Lesage, J., Cataldo, D., & Gilles, C. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12095 · Cited by 566
Zhong, Z., Huang, M., Lv, M., He, Y., Duan, C., Zhang, L., & Chen, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.027 · Cited by 449
Metadata
- Authors
- Moustakas, A., & Heldin, C.-H.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2016-06-29
- Volume
- 5
- Issue
- 7
- Pages
- 63
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W2474397968
- Cited by
- 267
- References
- 216
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.